Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey

New Microbiologica

Volumn 31, Issue 4, 2008, Pages 451-455

  Uyar, Yavuz ^a,b   Balci, Alaaddin ^a   Akcali, Alper ^b   Cabar, Cevat ^a  

^a Samsun Maternity and Women's Disease and Pediatrics Hospital   (Turkey)

^b Refik Saydam Hygiene Center   (Turkey)

Author keywords

Antibody; Cytomegalovirus; Pregnant women; Prevalence; Rubella

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; RUBELLA; RUBELLA VIRUS; TURKEY (REPUBLIC); VIROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; RUBELLA; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; TURKEY; YOUNG ADULT;

CYTOMEGALOVIRUS; RUBELLA;

EID: 57349140728     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AKSIT S., TIMOCIN A., TURPCULU A. (1999). Rubella immunity in pregnant Turkish women. Int. J. Gynaecol. Obstet. 66, 33-34.
2. ALANEN A., KAHALA K., VAHLBERG T., KOSKELA P., VAINIONPAA R. (2005). Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 112 (1): 50-56.
3. ALFORD C.A., STAGNO S., PASS R.F., BRITT WJ. (1990). Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12 (Suppl 7), S745-53.
4. ALTINDIS M., TANIR H.M. (2002). Gebe kadinlarda Toxoplasma gondii ve Sitomegalovirus antikorlari sikliǧi. Genel. Tip. Dergisi. 12 (1), 9-13.
5. AMERICAN ACADEMY OF PEDIATRICS, AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS (2002). Guidelines for perinatal care. 5th ed. Elk Grove Village (IL): AAP; Washington, DC: ACOG.
6. BEST J.M., BANATVALA J.E. (2004). Rubella. In: Principles and Practice of Clinical Virology. Eds. Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD), Fifth Edition, John Wiley and Sons, Ltd., West Suusex, England. 427-457.
7. BOPPANA S.B., PASS R.F., BRITT W.J., STAGNO S., ALFORD. C.A. (1992). Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11, 93-99.
8. BUKBOK D.N., EL NAFATY A.U., OBED J.Y. (2002). Prevalence of rubella-specific IgG antibody in nonimmunized pregnant women in Maiduguri, North Eastern Nigeria. Cent. Eur. J. Public. Health. 10(1-2), 21-23.
9. CENGIZ S.A., CENGIZ L., US E., CENGIZ T. (2005). Investigation of rubella IgG and IgM antibodies with ELISA in pregnants' sera. Turkish J. Infect. 19 (1), 19-24.
10. DE SANTIS M., CAVALIERE A.F., STRAFACE G., CARUSO A. (2006). Rubella infection in pregnancy. Reproductive Toxicol. 21, 390-398.
11. DESINOR O.Y., ANSELME R.J., LAENDER F., SAINT-LOUIS C., BIEN-AIME J.E. (2004). Seroprevalence of antibodies against rubella virus in pregnant women in Haiti. Rev. Panam. Salud. Publica. 15 (3), 147-150.
12. GHAZI H.O., TELMESANI A.M., MAHOMED M.F. (2002). TORCH Agents in Pregnant Saudi Women. Med. Princ. Pract. 11, 180-182.
13. GRATACAP-CAVALLIER B., BOSSON J.L., MORAND P., DUTERTRE N., CHANZY B., JOUK P.S., VANDEKERCKHOVE C., CART-LAMY P., SEIGNEURIN J.M. (1998). Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur. J. Epidemiol. 14 (2), 147-152.
14. GRIFFITHS P., BABONIAN C., ASHBY D. (1985). The demographic characteristics of pregnant womwn infected with cytomegalovirus. Int. J. Epidemiol. 14, 447-452.
15. GRIFFITHS P.D. (2004). Cytomegalovirus (In: Principles and Practice of Clinical Virology. Eds. Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD), Fifth Edition, John Wiley and Sons, Ltd., West Suusex, England. 85-122.
16. HAAS D.M., FLOWERS C.A., CONGDON C.L. (2005). Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating. Obstet. Gynecol. 106 (2), 295-300.
17. Ho M. (1990). Epidemiology of cytomegalovirus infections. Rev. Infect. Dis. 12 (Suppl 7), S701-710.
18. KARAKOC G.B., ALTINTAS D.U., KILINC B., KARABAY A., MUNGAN N.O., YILMAZ M., EVLIYAOGLU N. (2003). Seroprevalence of rubella in school girls and pregnant women. Eur. J. Epidemiol. 18(1), 81-84.
19. LEBLEBICIOǦLU H., GÜNAYDIN M., DURUPINAR B., PIRINÇÇILER M. (1992). Doǧurganlik yaş grubundaki kadinlarda anti-rubella anti-toxoplazma ve anti CMV antikorlarinin daǧilimi. Ank. Hst. Tip. Bült. 27, 39-42.
20. LEE J. Y., BOWDEN D.S. (2000). Rubella virus replication and links to teratogenicity. Clin. Microbiol. Rev. 13 (4), 571-587.
21. OCAK S., ZETEROGLU S., OZER C., DOLAPCIOGLU K., GUNGOREN A. (2007). Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand. J. Infect. Dis. 39(3), 231-234.
22. ODLAND J.O., SERGEJEVA I.V., IVANEEV M.D., JENSEN I.P., STRAY-PEDERSEN B. (2001). Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta. Obstet. Gynecol. Scand. 80 (11), 1025-1029.
23. PALIHAWADANA P., WICKREMASINGHE A.R., PERERA J. (2003). Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast. Asian. J. Trop. Med. Public. Health. 34 (2), 398-404.
24. PEHLIVAN E., KARAOGLU L., OZEN M., GUNES G., TEKEREKOGLU M.S., GENC M.F., EGRI M., ERCAN C. (2007). Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public. Health. 121, 462-468.
25. ROBERTSON S.E., FEATHERSTONE D.A., GACIC- DOBO M., HERSH B.S. (2003). Rubella and congenital rubella syndrome: global update. Rev. Panam. Salud. Publica. 14, 306-315.
26. SATILMIŞ A., GÜRA A., ONGUN H., MENDILCIOGLU I., ÇOLAK D., OYGÜR N. (2007). CMV seroconversion in pregnants and the incidence of congenital CMV infection. Turkish. J. Pediatr. 49, 30-36.
27. STAGNO S., PASS R.F., CLOUD G., BRITT W.J., HENDERSON R.E., WALTON P.D., VEREN D.A., PAGE E., ALFROD C.A. (1986). Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA. 256 (14), 1904-1948.
28. TOLFVENSTAM T., ENBOM M., GHEBREKIDAN H., RUDEN U., LINDE A., GRANDIEN M., WAHREN B. (2000). Seroprevalence of viral childhood infections in Eritrea. J. Clin. Virol. 16 (1), 49-54.
29. WONG A., TAN K.H., TEE C.S., YEO C.S.H. (2000). Seroprevalence of Cytomegalovirus, Toxoplasma and Parvovirus in Pregnancy. Singapore. Med. J. 41 (4), 151-155.
30. YILMAZER M., ALTINDIS M., CEVRIOGLU S., FENKCI V., AKTEPE O., SIRTHAN E. (2004). Toxoplasma, Cytomegalovirus, Rubella, Hepatitis B and Hepatitis C seropositivity rates in pregnant women who live in Afyon Region. Medical J. Kocatepe. 49-53.
31. YÜCEL A., BOZDAYI B., IMIR T. (2002). Seroprevalence of TORCHE antibodies among pregnant women in Gazi University Hospital. Turkish J. Infect. 16 (3), 279-283.